x.com· @ · X·· 2026-04-22Score60
Reading
MRD / ctDNA / DTP: from detection to treatment decisions
CheckMate 77T used this path: 75% clearance on nivolumab versus 46% on placebo.
Body
What is the impact of circulating tumor cell testing in clinical research? Hear from @pashtoonkasi (City of Hope) on the insights that CTCs uniquely give you, and how they complement tissue-based and circulating tumor DNA approaches.
#AACR26 #AACR2026 #LiquidBiopsy https://t.co/gPOtTRnNn1
Heat 13 · 4 likes · 3 replies · 6 reposts
Source: x.com · x.com